Dilip Shanghvi, Founder & Managing Director, Sun Pharmaceutical Industries, on Saturday dropped hints that the company could ...

Biogen’s disappointing Leqembi performance and weak pipeline hurt future growth. Learn why BIIB stock is rated "sell" due to ...

Unlicensed pharmacies purporting to sell pharmaceutical drugs are thriving despite the efforts by the U.S. Drug Enforcement Administration to stop them.

Elite Pharmaceuticals ( ($ELTP) ) has released its Q3 earnings. Here is a breakdown of the information Elite Pharmaceuticals presented to its ...

Wide-moat GE HealthCare, or GEHC, is a top three global leader in the medical imaging market. It has a firmly established footprint in hospitals and health networks around the world, and it is ...

Following the earnings announcement, WST stock plummeted 38% due to its disappointing guidance. Over a broader timeframe, its ...

These customized levies, expected to be finalized by April, are designed to rebalance trade relationships and target unfair ...

India's Glenmark Pharmaceuticals reported third-quarter profit below estimates on Friday due to bleak U.S. demand for its long-term illness drugs.

Photo: Commerce Secretary nominee Howard Lutnick listens as President Donald Trump speaks after signing an executive order in ...

Moderna is revamping its digital team, eliminating 10% of roles under two digital departments, affecting about 50 employees, ...

Over $600 billion in European goods were imported by the U.S. last year. New tariffs from President Trump will likely hit ...

Alnylam Pharmaceuticals exceeded Wall Street's expectations with strong revenue growth and significant commercial progress.